9 Results for "

PDE5A

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "PDE5A" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-112831
CAS No.: 1189767-28-9
Purity:  99.88%
Synonyms: BI-409306
Research Areas:  

Neurological Disease

Osoresnontrine (BI-409306) is a potent and selective PDE9A inhibitor, with an IC50 of 52 nM, and shows weak activity against other PDEs, such as PDE1A (IC50, 1.4 µM), PDE1C (IC50, 1.0 µM), PDE2A, PDE3A, PDE4B, PDE5A, PDE6AB, PDE7A, and PDE10A (IC50 all > 10 μM); Osoresnontrine can be used in the research of memory enhancement in CNS disorders.
loading...
    loading...
Cat. No.: HY-106230A
CAS No.: 569351-91-3
Purity:  98.35%
Synonyms: SCH-446132
Research Areas:  

Others

Dasantafil (SCH-446132) is a small molecule phosphodiesterase-5A (PDE5A) inhibitor used to in genitourinary disorders and study erectile dysfunction .
loading...
    loading...
Cat. No.: HY-RS10227
Research Areas:  

Others

PDE5A Human Pre-designed siRNA Set A contains three designed siRNAs for PDE5A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS10228
Research Areas:  

Others

Pde5a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pde5a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS10229
Research Areas:  

Others

Pde5a Rat Pre-designed siRNA Set A contains three designed siRNAs for Pde5a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-161851
Research Areas:  

Metabolic Disease

MDL3 is a novel inhibitor of PDE4B and PDE5A. MDL3 against liver injury and inflammation and inhibits the pathological remodeling of adipose tissue .
loading...
    loading...
Cat. No.: HY-170435
Research Areas:  

Cardiovascular Disease

PDE5-IN-13 (Compound 14b) inhibits phosphodiesterase 5 (PDE5A) with an IC50 of 3 nM. PDE5-IN-13 is a potential candidate for PAH (pulmonary arterial hypertension) research. PDE5-IN-13 has high selectivity for targets over PDE1, PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11. PDE5-IN-13 is orally active .
loading...
    loading...
Cat. No.: HY-P71591
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PDE5A; CGMP-Binding CGMP-Specific 3',5'-Cyclic Nucleotide Phosphodiesterase; Phosphodiesterase 5A; CGMP-Binding CGMP-Specific Phosphodiesterase; CGMP-Specific 3',5'-Cyclic Phosphodiesterase; CGMP-Specific Phosphodiesterase PDE5A1; CGMP-Specific Phosphodie
Species:  
Mouse
Source:  
E. coli
loading...
    loading...
loading...
    loading...